Ami Organics Ltd. (AMIORG) AI Stock Analysis

• Market Cap: ₹156.36B
• Dividend Yield: 0.09%
• Average Volume (3M): 14.81K
• Price to Earnings (P/E): 54.5
• Beta (1Y): 1.30
• Revenue Growth: 34.62%
• EPS Growth: 126.53%
• Country: IN
• Employees: 676
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 13.10
• Shares Outstanding: 81,871,124
• 10 Day Avg. Volume: 15,850
• 30 Day Avg. Volume: 14,806
• PEG Ratio: -0.98
• Price to Book (P/B): 3.03
• Price to Sales (P/S): 2.85
• P/FCF Ratio: -13.12
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 75 Outperform
• Price Target: ₹2,098.00 ▲(20.08% Upside)

The score is driven primarily by strong financial performance (high growth and margins plus an exceptionally low-leverage balance sheet). Technicals also support the case with a clear uptrend, though momentum is nearing overbought levels. The main drawback is valuation, with a high P/E, and cash flow remains a notable risk due to negative free cash flow.

Positive Factors

Revenue Growth

The significant revenue growth indicates expanding market reach and effective business strategies, supporting long-term sustainability.

Balance Sheet Health

Minimal reliance on debt financing enhances financial stability and flexibility, reducing risk and supporting future growth.

Profitability

Improved profitability reflects efficient operations and cost management, contributing to sustainable earnings and competitive positioning.

Negative Factors

Cash Flow Challenges

Negative free cash flow indicates high capital expenditures, which can strain liquidity and limit investment capacity in the long term.

EBITDA Margin Pressure

A declining EBITDA margin suggests rising non-operating costs, potentially impacting profitability and operational efficiency over time.

High Capital Expenditures

High capital expenditures can limit cash availability for other strategic initiatives, affecting long-term financial flexibility and growth potential.

Ami Organics Ltd. Business Overview & Revenue Model

Company Description

Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India. The company offers approximately 450 pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-parkinson, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides preservatives, such as parabens and parabens formulations for use in cosmetics, animal food, and personal care industries; and specialty chemicals for use in cosmetics, dyes, polymers, and agrochemicals. In addition, the company exports its products. Ami Organics Limited was founded in 2004 and is based in Surat, India.

How the Company Makes Money

Ami Organics generates revenue through the sale of its specialty chemicals and intermediates to various industries, including agriculture, pharmaceuticals, and personal care. The company’s revenue model is primarily based on direct sales to customers, which include both domestic and international clients. Key revenue streams include the production of agrochemical intermediates, pharmaceutical ingredients, and personal care products. Additionally, Ami Organics benefits from strategic partnerships with major players in these sectors, allowing them to expand their market reach and enhance their product offerings. The company's focus on research and development also positions it to capitalize on emerging market trends, further contributing to its earnings.

Ami Organics Ltd. Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2022	Dec 2021
Income Statement
Total Revenue	10.07B	10.07B	7.17B	5.18B	6.17B	3.41B
Gross Profit	4.03B	2.73B	2.63B	1.94B	2.86B	1.22B
EBITDA	2.43B	2.49B	1.04B	1.08B	1.27B	811.14M
Net Income	1.59B	1.59B	427.73M	719.46M	832.90M	539.99M
Balance Sheet
Total Assets	15.49B	15.49B	10.96B	6.59B	7.67B	4.13B
Cash, Cash Equivalents and Short-Term Investments	2.49B	2.49B	533.12M	615.46M	586.70M	26.85M
Total Debt	129.39M	129.39M	2.17B	8.44M	36.00M	1.37B
Total Liabilities	2.29B	2.29B	4.13B	1.37B	1.73B	2.46B
Stockholders Equity	13.10B	13.10B	6.74B	5.22B	5.94B	1.67B
Cash Flow
Free Cash Flow	0.00	-717.02M	-1.56B	-424.18M	-308.73M	-794.33M
Operating Cash Flow	0.00	1.23B	1.25B	-86.60M	655.30M	271.45M
Investing Cash Flow	0.00	-2.35B	-3.68B	-1.24B	-330.44M	-1.00B
Financing Cash Flow	0.00	2.67B	2.39B	1.40B	-122.50M	721.08M

Ami Organics Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1747.20
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:AMIORG, the sentiment is Positive. The current price of 1747.2 is above the 20-day moving average (MA) of 1724.10, above the 50-day MA of 1714.15, and above the 200-day MA of 1422.74, indicating a bullish trend. The MACD of 36.54 indicates Negative momentum. The RSI at 69.52 is Neutral, neither overbought nor oversold. The STOCH value of 89.23 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:AMIORG.

Ami Organics Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AMIORG	75 Outperform	₹156.36B	54.48	―	0.09%	34.62%	126.53%
BALAMINES	69 Neutral	₹36.22B	25.14	―	0.97%	-10.76%	-27.70%
ANURAS	66 Neutral	₹141.76B	91.26	―	0.06%	69.32%	113.55%
RALLIS	63 Neutral	₹53.43B	31.99	―	0.92%	0.91%	18.12%
HEG	62 Neutral	₹104.48B	40.51	―	0.33%	3.93%	41.77%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
ALKYLAMINE	61 Neutral	₹80.23B	44.04	―	0.62%	3.95%	8.28%